Cancer Survival Analysis
Guidelines for Writing Outcome
Targeted Cancer Therapies
Nursing Ethical Principles II
Treatment Resistant Cancers
Standards of Care II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 19, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX david.gerber@utsouthwestern.edu.
No abstract available in PubMed .